I notice some people mention about guidance on 17/8 INCLUDING VIFOR gains/savings.
That's is not correct.
At last announcement of CSL they informed the next report WILL NOT include VIFOR (obviously no time to study and analyse all income and savings with details ).
I copied the text from announcement, for the ones interested to confirm my comment.
CATO
"As completion of the acquisition of Vifor will occur shortly before CSL’s full year results announcement on 17 August 2022, CSL advises it will not be in a position to provide financial guidance relating to Vifor for fiscal 2023. Financial guidance for CSL will be provided as usual and will be updated to include Vifor at the first practicable opportunity. CSL intends to hold a dedicated Vifor market briefing on Monday 17 October 10am AEST. Investors will have an opportunity to hear from Vifor’s management team as well as CSL executives as they discuss Vifor’s growth strategy, insights into its product portfolio and financials."
CSL - $300 and beyond, page-30
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.26 |
Change
-1.400(0.46%) |
Mkt cap ! $145.3B | |||
| Open | High | Low | Value | Volume |
| $303.31 | $303.47 | $299.56 | $148.6M | 498.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 276 | $300.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $300.34 | 1250 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |